JP2003510255A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003510255A5 JP2003510255A5 JP2001525216A JP2001525216A JP2003510255A5 JP 2003510255 A5 JP2003510255 A5 JP 2003510255A5 JP 2001525216 A JP2001525216 A JP 2001525216A JP 2001525216 A JP2001525216 A JP 2001525216A JP 2003510255 A5 JP2003510255 A5 JP 2003510255A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- benzyl
- substituted
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001257 hydrogen Substances 0.000 description 23
- 229910052739 hydrogen Inorganic materials 0.000 description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 23
- 229910052731 fluorine Inorganic materials 0.000 description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 19
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 17
- 229910052801 chlorine Inorganic materials 0.000 description 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000011737 fluorine Substances 0.000 description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 239000003814 drug Substances 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 3
- 229910001413 alkali metal ion Inorganic materials 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 3
- -1 ammonium ions Chemical class 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 150000001768 cations Chemical group 0.000 description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 2
- 0 CC(CCC(I)=O)C1[C@@]2(C)C(C)(*)C[C@@]3[C@@](C)(CCC(C)(*)C4)[C@]4CC(*)(*)[C@]3[C@@]2CC1 Chemical compound CC(CCC(I)=O)C1[C@@]2(C)C(C)(*)C[C@@]3[C@@](C)(CCC(C)(*)C4)[C@]4CC(*)(*)[C@]3[C@@]2CC1 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1999145385 DE19945385A1 (de) | 1999-09-22 | 1999-09-22 | Substituierte 4-Benzylaminochinoline und ihre Heteroanlagen, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
| DE19945385.3-43 | 1999-09-22 | ||
| DE2000128193 DE10028193A1 (de) | 2000-06-09 | 2000-06-09 | Substituierte 4-Benzylamminochinoline und ihre Heteroanalogen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika, sowie sie enthaltende Medikamente |
| DE10028193.1 | 2000-06-09 | ||
| PCT/EP2000/008691 WO2001021642A1 (de) | 1999-09-22 | 2000-09-06 | 4-benzylaminochinoline konjugaten mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003510255A JP2003510255A (ja) | 2003-03-18 |
| JP2003510255A5 true JP2003510255A5 (enExample) | 2007-10-04 |
| JP4833471B2 JP4833471B2 (ja) | 2011-12-07 |
Family
ID=26005994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001525216A Expired - Fee Related JP4833471B2 (ja) | 1999-09-22 | 2000-09-06 | 胆汁酸との４−ベンジルアミノキノリン抱合体およびそれらのヘテロ類似体、それらの製造法、それらの化合物を含有する薬剤ならびにそれらの使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6339077B1 (enExample) |
| EP (1) | EP1218401B1 (enExample) |
| JP (1) | JP4833471B2 (enExample) |
| KR (1) | KR20030010575A (enExample) |
| CN (1) | CN1158299C (enExample) |
| AT (1) | ATE269352T1 (enExample) |
| AU (1) | AU779412B2 (enExample) |
| BR (1) | BR0014233A (enExample) |
| CA (1) | CA2385445A1 (enExample) |
| CZ (1) | CZ2002992A3 (enExample) |
| DE (1) | DE50006842D1 (enExample) |
| DK (1) | DK1218401T3 (enExample) |
| EE (1) | EE200200143A (enExample) |
| ES (1) | ES2218222T3 (enExample) |
| HK (1) | HK1049169B (enExample) |
| HR (1) | HRP20020238A2 (enExample) |
| HU (1) | HUP0203045A3 (enExample) |
| IL (1) | IL148739A0 (enExample) |
| NO (1) | NO20021337L (enExample) |
| NZ (1) | NZ517899A (enExample) |
| PL (1) | PL353992A1 (enExample) |
| PT (1) | PT1218401E (enExample) |
| RU (1) | RU2247125C2 (enExample) |
| SK (1) | SK3862002A3 (enExample) |
| WO (1) | WO2001021642A1 (enExample) |
| YU (1) | YU19302A (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6576644B2 (en) | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| ITMI20021025A1 (it) * | 2002-05-14 | 2003-11-14 | Nicox Sa | Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale |
| CZ301037B6 (cs) * | 2007-09-06 | 2009-10-21 | Vysoká škola chemicko-technologická v Praze | Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy |
| ES2488821T3 (es) * | 2009-03-24 | 2014-08-29 | Abbvie Bahamas Ltd. | Proceso de preparación de un compuesto antiviral |
| PH12012501846A1 (en) * | 2010-04-02 | 2013-02-04 | Firmenich Incorporated | Sweet flavor modifier |
| RU2617700C2 (ru) | 2011-08-12 | 2017-04-26 | Синомикс, Инк. | Производные 4-аминохинолин-3-карбоновой кислоты и содержащие их композиции для усиления сладкого вкуса |
| BR112017008738B1 (pt) | 2014-11-07 | 2021-06-15 | Firmenich Incorporated | Ácidos 4-amino-5-(ciclohexilóxi)quinolina-3-carboxílicos substituídos como modificadores de sabores adoçantes |
| WO2020041673A1 (en) | 2018-08-23 | 2020-02-27 | President And Fellows Of Harvard College | Compositions and methods related to cholic acid-7-sulfate as a treatment for diabetes |
| WO2020117945A1 (en) | 2018-12-04 | 2020-06-11 | President And Fellows Of Harvard College | Synthetic derivatives of cholic acid 7-sulfate and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4789678A (en) * | 1986-08-25 | 1988-12-06 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds |
| JPH0667846B2 (ja) * | 1989-04-28 | 1994-08-31 | 一 滝川 | 利胆剤 |
| IT1259419B (it) * | 1991-05-24 | 1996-03-18 | Erba Carlo Spa | Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi |
| TW289021B (enExample) * | 1993-05-08 | 1996-10-21 | Hoechst Ag | |
| IT1274000B (it) * | 1994-04-06 | 1997-07-14 | Alfa Wassermann Spa | Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi |
| DE4432708A1 (de) | 1994-09-14 | 1996-03-21 | Hoechst Ag | Modifizierte Gallensäuren, Verfahren zu ihrer Herstellung und ihre Verwendung |
| JPH09315979A (ja) * | 1996-05-24 | 1997-12-09 | Tokyo Tanabe Co Ltd | 利胆剤 |
| WO1998056757A1 (fr) * | 1997-06-11 | 1998-12-17 | Sankyo Company, Limited | Derives de benzylamine |
-
2000
- 2000-09-06 CZ CZ2002992A patent/CZ2002992A3/cs unknown
- 2000-09-06 DK DK00964126T patent/DK1218401T3/da active
- 2000-09-06 PT PT00964126T patent/PT1218401E/pt unknown
- 2000-09-06 YU YU19302A patent/YU19302A/sh unknown
- 2000-09-06 IL IL14873900A patent/IL148739A0/xx unknown
- 2000-09-06 SK SK386-2002A patent/SK3862002A3/sk unknown
- 2000-09-06 EP EP00964126A patent/EP1218401B1/de not_active Expired - Lifetime
- 2000-09-06 AT AT00964126T patent/ATE269352T1/de not_active IP Right Cessation
- 2000-09-06 CN CNB008131554A patent/CN1158299C/zh not_active Expired - Fee Related
- 2000-09-06 PL PL00353992A patent/PL353992A1/xx not_active Application Discontinuation
- 2000-09-06 EE EEP200200143A patent/EE200200143A/xx unknown
- 2000-09-06 WO PCT/EP2000/008691 patent/WO2001021642A1/de not_active Ceased
- 2000-09-06 DE DE50006842T patent/DE50006842D1/de not_active Expired - Lifetime
- 2000-09-06 BR BR0014233-6A patent/BR0014233A/pt not_active IP Right Cessation
- 2000-09-06 HK HK03101156.5A patent/HK1049169B/zh not_active IP Right Cessation
- 2000-09-06 HR HR20020238A patent/HRP20020238A2/xx not_active Application Discontinuation
- 2000-09-06 HU HU0203045A patent/HUP0203045A3/hu unknown
- 2000-09-06 NZ NZ517899A patent/NZ517899A/en unknown
- 2000-09-06 AU AU75156/00A patent/AU779412B2/en not_active Ceased
- 2000-09-06 ES ES00964126T patent/ES2218222T3/es not_active Expired - Lifetime
- 2000-09-06 RU RU2002110440/04A patent/RU2247125C2/ru not_active IP Right Cessation
- 2000-09-06 JP JP2001525216A patent/JP4833471B2/ja not_active Expired - Fee Related
- 2000-09-06 KR KR1020027003757A patent/KR20030010575A/ko not_active Ceased
- 2000-09-06 CA CA002385445A patent/CA2385445A1/en not_active Abandoned
- 2000-09-22 US US09/667,668 patent/US6339077B1/en not_active Expired - Lifetime
-
2002
- 2002-03-18 NO NO20021337A patent/NO20021337L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| JP2003501474A5 (enExample) | ||
| ES2189874T3 (es) | Dinucleotidos utiles para el tratamiento de enfermedades pulmonares. | |
| NO2009015I1 (no) | Fesoterodine, eventuelt i form av et fysiologisk akseptabelt salt, inkludert hydrogenfumaratsaltet | |
| KR960700708A (ko) | 3,4-디아릴크로만을 이용한 뼈 손실의 억제방법(methdos for inhibiting bone loss with 3,4-diarylchroman) | |
| MY125099A (en) | Comminuted form of (s)-2-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) penyl] propanoic acid | |
| RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
| JP2004502638A5 (enExample) | ||
| JP2003510255A5 (enExample) | ||
| SE8804692L (sv) | Nya 17b-oh-19-nor-steroider substituerade i 17 -staellning, foerfarande foer framstaellning daerav, anvaendning daerav som laekemedel och farmaceutiska kompositioner innehaallande dem | |
| MY135954A (en) | Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid | |
| JP2008013542A (ja) | 去痰又は気道杯細胞過形成抑制のための医薬組成物 | |
| HU200591B (en) | Process for producing new diphenyl propylamine derivatives and pharmaceutical compositions comprising such compounds | |
| JP2008512408A5 (enExample) | ||
| EP1184034A3 (en) | Oral drug composition containing a verapamil derivative as a drug-absorption promotor | |
| ATE84045T1 (de) | Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen. | |
| JP2002539089A5 (enExample) | ||
| JP2002509154A5 (enExample) | ||
| BR0016291A (pt) | Composto, uso do mesmo, métodos para a inibição das relaxações do esfìncter esofágico inferior transientes, para o tratamento da doença do refluxo gastroesofágico, da regurgitação em bebês, de nocicepção, êmese, dispepsia, ibs, soluços, adicção de cocaìna, dor, tosse, eructação, asma relacionada ou não com gord, e, formulação farmacêutica | |
| JP2003520208A5 (enExample) | ||
| RU2004133387A (ru) | Фармацевтический препарат с немедленным высвобождением | |
| DE69718077T2 (de) | Arzneimittel bestehend aus Diclofenac | |
| JP2002509858A5 (enExample) | ||
| DE3568440D1 (en) | New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them | |
| JP2005516035A5 (enExample) |